Pfizer and BioNTech Begin Phase 2/3 Clinical Trial for COVID-19 Vaccine Candidate in Germany

Pfizer Inc. (New York, NY, USA) and Biopharmaceutical New Technologies (BioNTech Mainz, Germany) have received approval from the German regulatory… COVID-19 | HospiMedica International BREAKING NEWS: As millions of Americans strive to deal with the economic downturn,loss of jobs,foreclosures,high cost … Read more…

Pfizer and BioNTech Complete Dosing for First Cohort of Phase 1/2 trial of COVID-19 Vaccine …

Pfizer Inc. (New York, NY, USA) and BioNTech SE (Mainz, Germany) have announced that the first cohort of BioNTech’s Phase… COVID-19 | HospiMedica International SPECIAL NEWS BULLETIN: Click today to request your free ACRX discount prescription card and save up … Read more…